Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial

Autor: Guerrieri-Gonzaga, Aliana, Serrano, Davide, Thomas, Parjhitham, Crew, Katherine D, Kumar, Nagi B, Gandini, Sara, Vornik, Lana A, Lee, Jack, Cagnacci, Sara, Vicini, Elisa, Accornero, Chiara A, D'Amico, Mauro, Guasone, Flavio, Spinaci, Stefano, Webber, Tania B, Brown, Powel H, Szabo, Eva, Heckman-Stoddard, Brandy, Bonanni, Bernardo

IntroductionAromatase inhibitors are effective in lowering breast cancer incidence among postmenopausal women, but adverse events represent a barrier to their acceptability and adherence as a preventive treatment. This study aims to assess whether lo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::393586cf5e2706e50b988a6a60a4221d
https://escholarship.org/uc/item/96z4x7hd

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Efficacy and safety of combination therapy with pegylated interferon and ribavirin in aged patients with chronic hepatitis C

Autor: Abbati, G., Ventura, Paolo, Sardini, Carla, Vegetti, A., Pileri, Francesca, Cagnacci, Sara, Venturelli, Giorgia, Incerti, Federica, Pietrangelo, Antonello

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3674::cad003441e487ac8e0eecfb14d558351
https://hdl.handle.net/11380/861772

Alternative dosing of exemestane in postmenopausal women with ER-positive breast cancer. Design and methods of a randomized presurgical trial.

Autor: Guerrieri-Gonzaga A; European Institute of Oncology IRCCS, Milan, Italy., Serrano D; European Institute of Oncology IRCCS, Milan, Italy. Electronic address: davide.serrano@ieo.it., Thomas P; University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Crew KD; Columbia University Irving Medical Center, New York, NY, USA., Kumar NB; Moffitt Cancer Center, University of South Florida, Tampa, FL, USA., Gandini S; European Institute of Oncology IRCCS, Milan, Italy., Vornik LA; University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Lee J; University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Cagnacci S; European Institute of Oncology IRCCS, Milan, Italy., Vicini E; European Institute of Oncology IRCCS, Milan, Italy., Accornero CA; European Institute of Oncology IRCCS, Milan, Italy., D'Amico M; Ospedali Galliera Genoa, Italy., Guasone F; Ospedale Villa Scassi ASL3, Genoa, Italy., Spinaci S; Ospedale Villa Scassi ASL3, Genoa, Italy., Webber TB; Ospedali Galliera Genoa, Italy., Brown PH; University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Szabo E; Division of Cancer Prevention, NCI, Bethesda, MD, USA., Heckman-Stoddard B; Division of Cancer Prevention, NCI, Bethesda, MD, USA., Bonanni B; European Institute of Oncology IRCCS, Milan, Italy.

Publikováno v: Contemporary clinical trials [Contemp Clin Trials] 2021 Aug; Vol. 107, pp. 106498. Date of Electronic Publication: 2021 Jul 01.